Hospital Universitario Basurto — Clinical Trial Site

161 Registered trials

68 Currently recruiting

Organisation

Hospital Universitario Basurto

Location

Bilbao, Spain

Identifier

ORG-100042026

Address

Montevideo Etorbidea 16-18, 48013, Spain

Departments

#034011 Oncología
#2602: Reumatología
#4201:Reumatología
1409:Alergología
2080: Hematología
2406: Reumatología
2406:Rheumatology
3127: Cardiología
3202: Hematologia
40269: Reumatología
4201:Reumatologia
7002: Oncología Médica
724003: Hematología
Alergologia
Allergology
Basurto_Cardiology Secretary
Cardiolog Department
Cardiología
Cardiology
cirugia
Cirugía Ortopédica y Traumatología.
Department of Urology
Dermatology
Dermatology department
Digestivo
Endocrinology and metabolism
General and Digestive Surgery
Hematología
Hematology
Hematology Service
Hospital de Basurto
Medical Oncology
N/A
Nephrology
Neumology
Neurology
Neurology Department
OFTALMOLOGIA
Oncolgy
Oncologia
ONCOLOGIA MEDICA
Oncology
Oncology Department
Psychiatry
Radiation Oncology
Reumathology
Reumatologia
Reumatology
Rheumatology
Rheumatology Dept
Rheumatology service
Servicio de Endocrinología
Servicio de enfermedades infecciosas
Servicio de Hematología
Servicio de Neumología
Servicio de Neurologia
Servicio de Oncología Médica
Servicio de Reumatología
Stroke Unit
Unidad de Pie Diabético
UROLOGIA
Urology

Clinical trials at this site (161)

Search interface

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatm… Ended

2023-505120-59-00 Moderate to Severe Plaque Psoriasis 5 2023-12-19
A randomized, double-blind 2-arm NEPTUNUS extension study to assess the long-term safety and efficacy of ianalumab in patients with Sjögren’… Ended

2022-502966-26-01 Sjögren’s syndrome 5 2023-10-27
Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With HR+/HER2− Metastatic Breast Cancer Who Have Received … Ended

2022-502593-17-00 Locally advanced or metastatic hormone receptor (HR)-po 5 2023-09-19
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS) Ended

2022-502700-78-00 Alopecia areata (AA) 5 2023-09-01
Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-2) Ended

2022-500700-22-00 Active Systemic Lupus Erythematosus (SLE) 5 2023-05-25
ETOP 22-22 ADEPPT: A study of adagrasib for patients with KRASG12C-mutant non-small cell lung cancer (NSCLC), who are elderly or who are unw… Ended

2023-510463-35-00 Patients with KRASG12C-mutant NSCLC, including patients 4 2023-04-26
ETOP 18-21 AMAZE-lung: A clinical study exploring the effect of amivantamab and lazertinib plus bevacizumab treatment, in people diagnosed w… Ended

2024-512288-29-00 Patients with EGFR-mutant (L858R or del19 only) advance 4 2023-04-11
A Study of Dato-DXd With or Without Durvalumab Versus Investigator’s Choice of Therapy in Patients With Stage I-III Triple-negative Breast C… Ended

2023-505552-22-00 Stage I-III Triple-negative Breast Cancer with residual 5 2023-02-24
A study of ONCOFID-P-B administered intravesically to patients with Carcinoma in Situ of the bladder who have not responded to the standard … Ended

2024-512568-72-00 BCG-unresponsive Carcinoma in Situ of the bladder with 5 2023-02-24
An open-label, single-arm, Phase II, multinational, multicentre study to assess the efficacy and safety of 5 years of osimertinib in partici… Ended

2023-508740-21-00 Non-Small Cell Lung Cancer 4 2023-02-15
A Study of Tirzepatide (LY3298176) on the Reduction of Morbidity and Mortality in Adults With Obesity (SURMOUNT- MMO) Ended

2022-501744-15-00 Obesity, Overweight 5 2023-01-23
Study of neoadjuvant patritumab deruxtecan with or without endocrine therapy in previously untreated patients – VALENTINE trial Ended

2023-503403-28-00 treatment naïve patients with HR+/HER2-negative high-ri 4 2022-11-25
Study of pembrolizumab, lenvatinib and chemotherapy combination in first line lung cancer Ended

2024-511412-25-00 First line treatment for extensive-stage small cell lun 4 2022-11-07
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable… Ended

2023-504195-14-00 PD-L1-negative metastatic triple-negative breast cancer 5 2022-08-31
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients with Paroxysmal Nocturnal… Ended

2023-509657-31-00 Paroxysmal nocturnal haemoglobinuria (PNH) 5 2022-08-24
Phase II study to evaluate diarrhoea discontinuations at 3 cycles in patients with early-stage HER2 positive, hormone receptor positive brea… Ended

2024-514630-21-00 HER2 positive (HER2+), Hormone Receptor positive (HR+) 4 2022-08-11
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients with Multiple Sclerosis Ended

2023-505974-14-00 Multiple Sclerosis (MS) 5 2022-06-23
A research study to evaluate the activity of Sotorasib for the treatment of patients with non-operable non-small cell lung cancer with a KRA… Ended

2024-511268-10-00 Unresectable stage III (IIIA-N2, IIIB, IIIC) KRAS p.G12 4 2022-05-25
A Phase 3 Single-Arm Study of UGN-102 for Treatment of LG IR NMIBC Ended

2023-506680-34-00 Non-Muscle Invasive Bladder Cancer 5 2022-03-24
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Inoperable or Metastatic Hormone Receptor-positive, HER2-negative Breast Ca… Ended

2023-509631-37-00 "Inoperable or Metastatic Hormone Receptor-Positive, HE 5 2022-01-18
A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Patients with Systemic Lupus Erythematosus (ALLEGORY) Ended

2023-504774-38-00 Systemic Lupus Erythematosus (SLE) 5 2021-11-04
Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissecti… Ended

2024-516039-28-00 Spontaneous Coronary Artery Dissection. 6 2021-09-28
Guselkumab versus Placebo for the Treatment of Psoriatic Arthritis Axial Disease in Bio-naive Participants Ended

2023-504716-15-00 Psoriatic Arthritis 6 2021-08-06